| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BDRC.21107 |
| P698 | PubMed publication ID | 26396056 |
| P50 | author | Andrew S Brohl | Q57430938 |
| P2093 | author name string | Clifton O'neill Brock | |
| Sarah Gloria Običan | |||
| P2860 | cites work | Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients | Q43519903 |
| Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. | Q43626449 | ||
| Antiphospholipid antibodies and stroke in young women | Q44168396 | ||
| Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly pr | Q45101265 | ||
| Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation | Q45111033 | ||
| Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial | Q46125985 | ||
| Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome | Q46179258 | ||
| Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study | Q46343093 | ||
| Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease | Q46745537 | ||
| Antiphospholipid antibodies in stillbirth | Q47128289 | ||
| The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. | Q47856584 | ||
| Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings | Q48371040 | ||
| Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. | Q51826601 | ||
| Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. | Q53159273 | ||
| Catastrophic antiphospholipid syndrome: task force report summary. | Q54037099 | ||
| Antiphospholipid syndrome | Q55891386 | ||
| Maternal age and fetal loss: population based register linkage study | Q24656936 | ||
| Antiphospholipid syndrome and recurrent miscarriages | Q28182092 | ||
| Thrombosis and the antiphospholipid syndrome | Q28193514 | ||
| Management of antiphospholipid antibody syndrome: a systematic review | Q28195454 | ||
| CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS | Q28201845 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients | Q33369688 | ||
| Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis | Q33384580 | ||
| Diagnosis and classification of the antiphospholipid syndrome | Q33412887 | ||
| Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset | Q33418783 | ||
| Antiphospholipid syndrome and the skin | Q33499667 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Epidemiology of the antiphospholipid antibody syndrome | Q33916234 | ||
| Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies | Q33937799 | ||
| Global and regional estimates of preeclampsia and eclampsia: a systematic review | Q34349387 | ||
| 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends | Q34400373 | ||
| Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Q34788539 | ||
| Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension | Q35552039 | ||
| Management of the obstetric antiphospholipid syndrome | Q35743192 | ||
| Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases | Q35953379 | ||
| Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) | Q36242479 | ||
| Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies | Q36787727 | ||
| Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? | Q36832533 | ||
| Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale? | Q37547996 | ||
| Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression | Q37645693 | ||
| Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis | Q37760751 | ||
| Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis | Q37811769 | ||
| HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies | Q37922364 | ||
| Valvular heart disease in antiphospholipid syndrome | Q38086166 | ||
| The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies | Q39596940 | ||
| Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study | Q40533021 | ||
| Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism | Q41099260 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 201-208 | |
| P577 | publication date | 2015-09-23 | |
| P1433 | published in | Birth Defects Research Part C: Embryo Today Reviews | Q15757886 |
| P1476 | title | Incidence, pathophysiology, and clinical manifestations of antiphospholipid syndrome | |
| P478 | volume | 105 |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.